Page last updated: 2024-10-29

amrinone and Carditis

amrinone has been researched along with Carditis in 2 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sasayama, S1
Matsumori, A1
Seta, Y1
Kanda, T1
Yokoyama, T1
Kobayashi, I1
Suzuki, T1
Nagai, R1

Other Studies

2 other studies available for amrinone and Carditis

ArticleYear
Role of cytokines in the syndrome of heart failure.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:1

    Topics: Adrenergic beta-Agonists; Amrinone; Animals; Cardiotonic Agents; Cytokines; Heart Failure; Humans; K

1996
Effect of amrinone on murine viral myocarditis.
    Research communications in molecular pathology and pharmacology, 1997, Volume: 95, Issue:1

    Topics: Acute Disease; Amrinone; Animals; Cells, Cultured; Cyclic AMP; Female; Heart; Mice; Mice, Inbred C3H

1997